Research Triangle Park, North Carolina (ots/PRNewswire)
- Now has clinical development offices in eight Asia countries
Quintiles Transnational Corp. today announced the extension of its
Asia operations with the opening of an office in Hanoi, Vietnam.
"Vietnam is an increasingly important market in the region, with
its population of 80 million, a strong educational system and a
robust healthcare industry," said Michael Stibilj, Executive
Director, Clinical Development Services, Southeast Asia. "Economic
growth in Vietnam has been averaging more than 7.5% over the past 10
In addition to its large population, Vietnam has an urban hospital
infrastructure comparable to other Southeast Asian countries, doctors
who have trained in Europe or the U.S., and tremendous motivation to
participate in international clinical trials, Stibilj said. The
Vietnam Ministry of Health recently issued a revised set of
guidelines for the conduct of clinical trials, thereby setting a
consistent regulatory framework for clinical trials.
Quintiles will also work closely with the Vietnam Ministry of
Health to increase the number of sites trained in Good Clinical
Practice, which are the regulatory standards designed to assure the
accuracy of information obtained in clinical trials while protecting
the rights and confidentiality of patients and other volunteers
participating in the trials.
Stibilj added, "The opening of our representative office shows our
commitment to our customers wanting to work in Vietnam and to the
development of the clinical research industry in Vietnam and the
region." Quintiles emphasizes local language skills, clinical
knowledge and regulatory expertise, so Vietnamese clinical research
monitors will be employed by Quintiles in Vietnam, he said.
About Quintiles East Asia
Quintiles has clinical development offices across eight countries
in its East Asia region, including China, Malaysia, the Philippines,
Singapore, South Korea, Taiwan, Thailand and Vietnam. Since 1995 the
Quintiles clinical team in Asia has completed over 160 Phase II and
III studies from 1,000 sites and recruited over 35,000 patients into
international clinical trials. Quintiles lab operations in Singapore
and Beijing have serviced more than 200 studies with samples shipped
in from 15 Asia Pacific countries, making Quintiles the leading
pharmaceutical development provider in the region.
Quintiles is the global leader in pharmaceutical services. We
improve healthcare worldwide by providing quality professional
expertise, market intelligence and innovative partnering solutions to
the pharmaceutical, biotechnology and healthcare industries.
Quintiles has 16,000 specialized employees and offices in 50
countries. For more information visit the company's Web site at
Web site: http://www.quintiles.com
ots Originaltext: Quintiles Transnational Corp.
Im Internet recherchierbar: http://www.presseportal.ch
Media Relations, Dick Jones, +1-919-998-2091, or
, or Investor Relations, Greg Connors,
+1-919-998-2000, or email@example.com
, both of Quintiles